{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:33:58Z","timestamp":1771875238175,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T00:00:00Z","timestamp":1513209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00105-017-4089-y","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T12:56:44Z","timestamp":1513256204000},"page":"67-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Schleimhautpemphigoid","Mucous membrane pemphigoid"],"prefix":"10.1007","volume":"69","author":[{"given":"M. M.","family":"Holtsche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"key":"4089_CR1","first-page":"370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ et\u00a0al (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138:370\u2013379","journal-title":"Arch Dermatol"},{"key":"4089_CR2","series-title":"Rook\u2019s textbook of dermatology, part 3","first-page":"1","volume-title":"Infections & infestations","author":"E Schmidt","year":"2016","unstructured":"Schmidt E, Groves R (2016) Immunobullous diseases. In: Griffith C, Barker J, Chalmers, Bleiker T, Creamer D (Hrsg) Rook\u2019s textbook of dermatology, part\u00a03. 9.\u00a0Aufl. Wiley-Blackwell, Chichester, S 1\u201356","edition":"9"},{"key":"4089_CR3","first-page":"434","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram F, Brocker EB, Zillikens D et\u00a0al (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J\u00a0Dtsch Dermatol Ges 7:434\u2013440","journal-title":"J Dtsch Dermatol Ges"},{"issue":"12","key":"4089_CR4","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","volume":"136","author":"F Hubner","year":"2016","unstructured":"Hubner F, Recke A, Zillikens D et\u00a0al (2016) Prevalence and sge distribution of pemphigus and pemphigoid diseases in Germany. J\u00a0Invest Dermatol 136(12):2495\u20132498. \n                        https:\/\/doi.org\/10.1016\/j.jid.2016.07.013","journal-title":"J Invest Dermatol"},{"key":"4089_CR5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-4362.1986.tb04544.x","volume":"25","author":"AR Ahmed","year":"1986","unstructured":"Ahmed AR, Hombal SM (1986) Cicatricial pemphigoid. Int J Dermatol 25:90\u201396","journal-title":"Int J Dermatol"},{"key":"4089_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.md.0000231954.08350.52","volume":"85","author":"M Alexandre","year":"2006","unstructured":"Alexandre M, Brette MD, Pascal F et\u00a0al (2006) A prospective study of upper aerodigestive tract manifestations of mucous membrane pemphigoid. Medicine (Baltimore) 85:239\u2013252","journal-title":"Medicine (Baltimore)"},{"key":"4089_CR7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bjo.2006.092528","volume":"90","author":"GT Higgins","year":"2006","unstructured":"Higgins GT, Allan RB, Hall R et\u00a0al (2006) Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa. Br J Ophthalmol 90:964\u2013967","journal-title":"Br J Ophthalmol"},{"key":"4089_CR8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0030-4220(82)90080-9","volume":"54","author":"G Laskaris","year":"1982","unstructured":"Laskaris G, Sklavounou A, Stratigos J (1982) Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris. A comparative clinical survey of 278 cases. Oral Surg Oral Med Oral Pathol 54:656\u2013662","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"4089_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","volume":"111","author":"JE Thorne","year":"2004","unstructured":"Thorne JE, Anhalt GJ, Jabs DA (2004) Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 111:45\u201352","journal-title":"Ophthalmology"},{"key":"4089_CR10","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","volume":"357","author":"CA Egan","year":"2001","unstructured":"Egan CA, Lazarova Z, Darling TN et al (2001) Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 357:1850\u20131851","journal-title":"Lancet"},{"key":"4089_CR11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","volume":"135","author":"M Leverkus","year":"1999","unstructured":"Leverkus M, Schmidt E, Lazarova Z et\u00a0al (1999) Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol 135:1091\u20131098","journal-title":"Arch Dermatol"},{"key":"4089_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1346-8138.2004.tb00497.x","volume":"31","author":"S Matsushima","year":"2004","unstructured":"Matsushima S, Horiguchi Y, Honda T et al (2004) A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy. J\u00a0Dermatol 31:10\u201315","journal-title":"J Dermatol"},{"key":"4089_CR13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2230.2007.02463.x","volume":"32","author":"E Letko","year":"2007","unstructured":"Letko E, Gurcan HM, Papaliodis GN et\u00a0al (2007) Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit. Clin Exp Dermatol 32:637\u2013641","journal-title":"Clin Exp Dermatol"},{"key":"4089_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0714.2006.00483.x","volume":"36","author":"M Malik","year":"2007","unstructured":"Malik M, Gurcan HM, Christen W et al (2007) Relationship between cancer and oral pemphigoid patients with antibodies to alpha6-integrin. J\u00a0Oral Pathol Med 36:1\u20135","journal-title":"J Oral Pathol Med"},{"key":"4089_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2133.1991.tb06077.x","volume":"125","author":"M Nayar","year":"1991","unstructured":"Nayar M, Wojnarowska F (1991) No association between cicatricial pemphigoid and malignant disease. Br J Dermatol 125:193\u2013194","journal-title":"Br J Dermatol"},{"key":"4089_CR16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2133.2001.04448.x","volume":"145","author":"M Carrozzo","year":"2001","unstructured":"Carrozzo M, Fasano ME, Broccoletti R et al (2001) HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Br J Dermatol 145:805\u2013808","journal-title":"Br J Dermatol"},{"key":"4089_CR17","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","volume":"93","author":"JC Delgado","year":"1996","unstructured":"Delgado JC, Turbay D, Yunis EJ et al (1996) A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA 93:8569\u20138571","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4089_CR18","first-page":"330","volume":"8","author":"M Drouet","year":"1998","unstructured":"Drouet M, Delpuget-Bertin N, Vaillant L et al (1998) HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French caucasians. Eur J Dermatol 8:330\u2013333","journal-title":"Eur J Dermatol"},{"key":"4089_CR19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0190-9622(91)70299-H","volume":"25","author":"M Nayar","year":"1991","unstructured":"Nayar M, Wojnarowska F, Venning V et\u00a0al (1991) Association of autoimmunity and cicatricial pemphigoid: is there an immunogenetic basis? J\u00a0Am Acad Dermatol 25:1011\u20131015","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2133.2001.04380.x","volume":"145","author":"J Setterfield","year":"2001","unstructured":"Setterfield J, Theron J, Vaughan RW et al (2001) Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol 145:406\u2013414","journal-title":"Br J Dermatol"},{"key":"4089_CR21","doi-asserted-by":"crossref","first-page":"7747","DOI":"10.1073\/pnas.91.16.7747","volume":"91","author":"JJ Yunis","year":"1994","unstructured":"Yunis JJ, Mobini N, Yunis EJ et\u00a0al (1994) Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci USA 91:7747\u20137751","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4089_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13464","author":"CD Sadik","year":"2017","unstructured":"Sadik CD, Bischof J, Beek NV et al (2017) Genome-wide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid. Exp Dermatol. \n                        https:\/\/doi.org\/10.1111\/exd.13464","journal-title":"Exp. Dermatol."},{"key":"4089_CR23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0190-9622(91)70159-Y","volume":"24","author":"AR Ahmed","year":"1991","unstructured":"Ahmed AR, Kurgis BS, Rogers RS 3rd (1991) Cicatricial pemphigoid. J\u00a0Am Acad Dermatol 24:987\u20131001","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR24","first-page":"399","volume":"108","author":"E Schmidt","year":"2011","unstructured":"Schmidt E, Zillikens D (2011) The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int 108:399\u2013405","journal-title":"Dtsch Arztebl Int"},{"key":"4089_CR25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1542-0124(12)70281-1","volume":"6","author":"VP Saw","year":"2008","unstructured":"Saw VP, Dart JK (2008) Ocular mucous membrane pemphigoid: diagnosis and management strategies. Ocul Surf 6:128\u2013142","journal-title":"Ocul Surf"},{"key":"4089_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00347-008-1699-x","volume":"105","author":"E Schmidt","year":"2008","unstructured":"Schmidt E, Meyer-Ter-Vehn T, Zillikens D et al (2008) Mucous membrane pemphigoid with ocular involvement. Part I: clinical manifestations, pathogenesis and diagnosis. Ophthalmologe 105:285\u2013297","journal-title":"Ophthalmologe"},{"key":"4089_CR27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","volume":"89","author":"CS Foster","year":"1982","unstructured":"Foster CS, Wilson LA, Ekins MB (1982) Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 89:340\u2013353","journal-title":"Ophthalmology"},{"key":"4089_CR28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9394(14)77908-5","volume":"96","author":"BJ Mondino","year":"1983","unstructured":"Mondino BJ, Brown SI (1983) Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 96:453\u2013459","journal-title":"Am J Ophthalmol"},{"key":"4089_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","volume":"88","author":"BJ Mondino","year":"1981","unstructured":"Mondino BJ, Brown SI (1981) Ocular cicatricial pemphigoid. Ophthalmology 88:95\u2013100","journal-title":"Ophthalmology"},{"key":"4089_CR30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0002-9394(77)90546-3","volume":"83","author":"BJ Mondino","year":"1977","unstructured":"Mondino BJ, Ross AN, Rabin BS et\u00a0al (1977) Autoimmune phenomena in ocular cicatricial pemphigoid. Am J Ophthalmol 83:443\u2013450","journal-title":"Am J Ophthalmol"},{"key":"4089_CR31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00003226-199209000-00015","volume":"11","author":"J Tauber","year":"1992","unstructured":"Tauber J, Jabbur N, Foster CS (1992) Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea 11:446\u2013451","journal-title":"Cornea"},{"key":"4089_CR32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2014.08.024","volume":"72","author":"DF Murrell","year":"2015","unstructured":"Murrell DF, Marinovic B, Caux F et\u00a0al (2015) Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. J\u00a0Am Acad Dermatol 72:168\u2013174","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","volume":"154","author":"N Oyama","year":"2006","unstructured":"Oyama N, Setterfield JF, Powell AM et\u00a0al (2006) Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol 154:90\u201398","journal-title":"Br J Dermatol"},{"key":"4089_CR34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1523-1747.ep12329728","volume":"106","author":"SD Balding","year":"1996","unstructured":"Balding SD, Prost C, Diaz LA et\u00a0al (1996) Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J\u00a0Invest Dermatol 106:141\u2013146","journal-title":"J Invest Dermatol"},{"key":"4089_CR35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(03)00035-5","volume":"32","author":"JB Lee","year":"2003","unstructured":"Lee JB, Liu Y, Hashimoto T (2003) Cicatricial pemphigoid sera specifically react with the most C\u2011terminal portion of BP180. J\u00a0Dermatol Sci 32:59\u201364","journal-title":"J Dermatol Sci"},{"key":"4089_CR36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","volume":"149","author":"P Bernard","year":"2013","unstructured":"Bernard P, Antonicelli F, Bedane C et al (2013) Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a\u00a0novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol 149:533\u2013540","journal-title":"JAMA Dermatol"},{"key":"4089_CR37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jaad.2014.02.036","volume":"71","author":"S Goletz","year":"2014","unstructured":"Goletz S, Hashimoto T, Zillikens D et al (2014) Anti-p200 pemphigoid. J\u00a0Am Acad Dermatol 71:185\u2013191","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR38","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jid.2017.03.037","volume":"137","author":"EN Heppe","year":"2017","unstructured":"Heppe EN, Tofern S, Schulze FS et\u00a0al (2017) Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and Immunopathological characteristics of the human disease. J\u00a0Invest Dermatol 137:1709\u20131718","journal-title":"J Invest Dermatol"},{"key":"4089_CR39","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1172\/JCI118942","volume":"98","author":"Z Lazarova","year":"1996","unstructured":"Lazarova Z, Yee C, Darling T et al (1996) Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J\u00a0Clin Invest 98:1509\u20131518","journal-title":"J Clin Invest"},{"key":"4089_CR40","first-page":"2283","volume":"40","author":"RY Chan","year":"1999","unstructured":"Chan RY, Bhol K, Tesavibul N et\u00a0al (1999) The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 40:2283\u20132290","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4089_CR41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320\u2013332","journal-title":"Lancet"},{"issue":"4","key":"4089_CR42","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jaad.2017.05.016","volume":"77","author":"I Shimanovich","year":"2017","unstructured":"Shimanovich I, Nitz JM, Zillikens D (2017) Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid. J\u00a0Am Acad Dermatol 77(4):700\u2013705.e3. \n                        https:\/\/doi.org\/10.1016\/j.jaad.2017.05.016","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-662-45133-5_3","volume-title":"Histopathologie der Haut","author":"E Schmidt","year":"2016","unstructured":"Schmidt E, Zillikens D (2016) Immunfluoreszenztechniken. In: Cerroni L, Garbe C, Metze D, Kutzner H, Kerl H (Hrsg) Histopathologie der Haut, 2.\u00a0Aufl. Springer, Heidelberg, S\u00a037\u201349","edition":"2"},{"key":"4089_CR44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.12308","volume":"169","author":"JB Terra","year":"2013","unstructured":"Terra JB, Meijer JM, Jonkman MF et al (2013) The n\u2011 vs. u\u2011serration is a\u00a0learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis. Br J Dermatol 169:100\u2013105","journal-title":"Br J Dermatol"},{"key":"4089_CR45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","volume":"151","author":"RM Vodegel","year":"2004","unstructured":"Vodegel RM, Jonkman MF, Pas HH et al (2004) U\u2011serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 151:112\u2013118","journal-title":"Br J Dermatol"},{"key":"4089_CR46","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bjophthalmol-2012-302963","volume":"97","author":"AE Grau","year":"2013","unstructured":"Grau AE, Setterfield J, Saw VP (2013) How to do conjunctival and buccal biopsies to investigate cicatrising conjunctivitis: improving the diagnosis of ocular mucous membrane pemphigoid. Br J Ophthalmol 97:530\u2013531","journal-title":"Br J Ophthalmol"},{"key":"4089_CR47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/bjophthalmol-2015-306807","volume":"100","author":"HS Mudhar","year":"2016","unstructured":"Mudhar HS (2016) Biopsies of cicatricial conjunctivitis cases reveal highly variable sampling practice among ophthalmologists: time for national and international standardisation. Br J Ophthalmol 100:736\u2013744","journal-title":"Br J Ophthalmol"},{"key":"4089_CR48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2016.284","volume":"31","author":"JK Dart","year":"2017","unstructured":"Dart JK (2017) The 2016 Bowman lecture conjunctival curses: scarring conjunctivitis 30 years on. Eye (Lond) 31:301\u2013332","journal-title":"Eye (Lond)"},{"key":"4089_CR49","first-page":"1268","volume":"13","author":"T Mehra","year":"2015","unstructured":"Mehra T, Guenova E, Dechent F et\u00a0al (2015) Diagnostic relevance of direct immunofluorescence in ocular mucous membrane pemphigoid. J\u00a0Dtsch Dermatol Ges 13:1268\u20131274","journal-title":"J Dtsch Dermatol Ges"},{"key":"4089_CR50","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/1523-1747.ep12876206","volume":"94","author":"P Bernard","year":"1990","unstructured":"Bernard P, Prost C, Lecerf V et\u00a0al (1990) Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J\u00a0Invest Dermatol 94:630\u2013635","journal-title":"J Invest Dermatol"},{"key":"4089_CR51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archderm.1997.03890450048006","volume":"133","author":"RF Ghohestani","year":"1997","unstructured":"Ghohestani RF, Nicolas JF, Rousselle P et al (1997) Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 133:1102\u20131107","journal-title":"Arch Dermatol"},{"key":"4089_CR52","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","volume":"145","author":"E Schmidt","year":"2001","unstructured":"Schmidt E, Skrobek C, Kromminga A et al (2001) Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 145:778\u2013783","journal-title":"Br J Dermatol"},{"key":"4089_CR53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1067\/mjd.2003.99","volume":"48","author":"RM Vodegel","year":"2003","unstructured":"Vodegel RM, De Jong MC, Pas HH et al (2003) Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy. J\u00a0Am Acad Dermatol 48:542\u2013547","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4089_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1684\/ejd.2015.2692","volume":"26","author":"ON Horvath","year":"2016","unstructured":"Horvath ON, Varga R, Kaneda M et al (2016) Diagnostic performance of the \u201cMESACUP anti-Skin profile TEST\u201d. Eur J Dermatol 26(1):56\u201363. \n                        https:\/\/doi.org\/10.1684\/ejd.2015.2692","journal-title":"Eur J Dermatol"},{"key":"4089_CR55","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2016.11.002","volume":"76","author":"N Beek Van","year":"2017","unstructured":"Van Beek N, Dahnrich C, Johannsen N et al (2017) Prospective studies on the routine use of a\u00a0novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. J\u00a0Am Acad Dermatol 76:889\u2013894","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1523-1747.ep12477198","volume":"97","author":"C Bedane","year":"1991","unstructured":"Bedane C, Prost C, Bernard P et\u00a0al (1991) Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a\u00a0study by indirect immunoelectronmicroscopy. J\u00a0Invest Dermatol 97:3\u20139","journal-title":"J Invest Dermatol"},{"key":"4089_CR57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0923-1811(97)00067-4","volume":"17","author":"H Murakami","year":"1998","unstructured":"Murakami H, Nishioka S, Setterfield J et\u00a0al (1998) Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J\u00a0Dermatol Sci 17:39\u201344","journal-title":"J Dermatol Sci"},{"key":"4089_CR58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1365-2133.1998.02168.x","volume":"138","author":"J Setterfield","year":"1998","unstructured":"Setterfield J, Shirlaw PJ, Kerr-Muir M et al (1998) Mucous membrane pemphigoid: a\u00a0dual circulating antibody response with IgG and IgA signifies a\u00a0more severe and persistent disease. Br J Dermatol 138:602\u2013610","journal-title":"Br J Dermatol"},{"key":"4089_CR59","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/bjd.14351","volume":"174","author":"S Ali","year":"2016","unstructured":"Ali S, Kelly C, Challacombe SJ et\u00a0al (2016) Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid. Br J Dermatol 174:1022\u20131029","journal-title":"Br J Dermatol"},{"key":"4089_CR60","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/bjd.14430","volume":"174","author":"E Schmidt","year":"2016","unstructured":"Schmidt E (2016) Increasing the diagnostic sensitivity for mucous membrane pemphigoid by detection of salivary autoantibodies. Br J Dermatol 174:956\u2013957","journal-title":"Br J Dermatol"},{"key":"4089_CR61","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jaad.2004.06.004","volume":"51","author":"Z Lazarova","year":"2004","unstructured":"Lazarova Z, Sitaru C, Zillikens D et al (2004) Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J\u00a0Am Acad Dermatol 51:886\u2013892","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1172-7-49","volume":"7","author":"N Beek Van","year":"2012","unstructured":"Van Beek N, Rentzsch K, Probst C et al (2012) Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis 7:49","journal-title":"Orphanet J Rare Dis"},{"key":"4089_CR63","volume-title":"Cell-based immunofluorescence test applying recombinant laminin 332 for the serological differential diagnosis of pemphigoid","author":"S Goletz","year":"2017","unstructured":"Goletz S, Probst C, Komorowski L et al (2017) Cell-based immunofluorescence test applying recombinant laminin 332 for the serological differential diagnosis of pemphigoid. Scientific Conference of the International Pemphigus & Pemphigoid Foundation, L\u00fcbeck."},{"key":"4089_CR64","first-page":"713","volume":"13","author":"E Schmidt","year":"2015","unstructured":"Schmidt E, Goebeler M, Hertl M et\u00a0al (2015) S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J\u00a0Dtsch Dermatol Ges 13:713\u2013727","journal-title":"J Dtsch Dermatol Ges"},{"key":"4089_CR65","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archderm.137.9.1181","volume":"137","author":"AR Ahmed","year":"2001","unstructured":"Ahmed AR, Colon JE (2001) Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy. Arch Dermatol 137:1181\u20131189","journal-title":"Arch Dermatol"},{"key":"4089_CR66","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaad.2013.01.046","volume":"69","author":"K Heelan","year":"2013","unstructured":"Heelan K, Walsh S, Shear NH (2013) Treatment of mucous membrane pemphigoid with rituximab. J\u00a0Am Acad Dermatol 69:310\u2013311","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR67","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","volume":"6","author":"M Hertl","year":"2008","unstructured":"Hertl M, Zillikens D, Borradori L et al (2008) Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases. J\u00a0Dtsch Dermatol Ges 6:366\u2013373","journal-title":"J Dtsch Dermatol Ges"},{"key":"4089_CR68","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jaad.2010.07.032","volume":"65","author":"M Kasperkiewicz","year":"2011","unstructured":"Kasperkiewicz M, Shimanovich I, Ludwig RJ et al (2011) Rituximab for treatment-refractory pemphigus and pemphigoid: a\u00a0case series of 17 patients. J\u00a0Am Acad Dermatol 65:552\u2013558","journal-title":"J Am Acad Dermatol"},{"key":"4089_CR69","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archdermatol.2011.54","volume":"147","author":"C Roux-Villet Le","year":"2011","unstructured":"Le Roux-Villet C, Prost-Squarcioni C, Alexandre M et al (2011) Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol 147:843\u2013849","journal-title":"Arch Dermatol"},{"key":"4089_CR70","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2003.11.002","volume":"111","author":"E Letko","year":"2004","unstructured":"Letko E, Miserocchi E, Daoud YJ et\u00a0al (2004) A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol 111:303\u2013310","journal-title":"Clin Immunol"},{"key":"4089_CR71","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","volume":"156","author":"E Schmidt","year":"2007","unstructured":"Schmidt E, Seitz CS, Benoit S et\u00a0al (2007) Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol 156:352\u2013356","journal-title":"Br J Dermatol"},{"key":"4089_CR72","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00105-011-2189-7","volume":"62","author":"A Recke","year":"2011","unstructured":"Recke A, Shimanovich I, Steven P et al (2011) Treatment-refractory anti-laminin 332 mucous membrane pemphigoid. Remission following adjuvant immunoadsorption and rituximab. Hautarzt 62:852\u2013858","journal-title":"Hautarzt"},{"key":"4089_CR73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00403-009-1024-9","volume":"302","author":"E Schmidt","year":"2010","unstructured":"Schmidt E, Zillikens D (2010) Immunoadsorption in dermatology. Arch Dermatol Res 302:241\u2013253","journal-title":"Arch Dermatol Res"},{"key":"4089_CR74","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1610-0387.2007.06342.x","volume":"5","author":"D Zillikens","year":"2007","unstructured":"Zillikens D, Derfler K, Eming R et\u00a0al (2007) Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases. J\u00a0Dtsch Dermatol Ges 5:881\u2013887","journal-title":"J Dtsch Dermatol Ges"},{"key":"4089_CR75","first-page":"833","volume":"13","author":"R Eming","year":"2015","unstructured":"Eming R, Sticherling M, Hofmann SC et\u00a0al (2015) S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J\u00a0Dtsch Dermatol Ges 13:833\u2013844","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"4089_CR76","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ajo.2010.11.011","volume":"151","author":"MF De La Paz","year":"2011","unstructured":"De La Paz MF, De Toledo JA, Charoenrook V et al (2011) Impact of clinical factors on the long-term functional and anatomic outcomes of osteo-odonto-keratoprosthesis and tibial bone keratoprosthesis. Am J Ophthalmol 151(5):829\u2013839.e1","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"4089_CR77","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/ddg.13317","volume":"15","author":"E Schmidt","year":"2017","unstructured":"Schmidt E, Benoit S, Kampik D et\u00a0al (2017) Tibial bone keratoprosthesis: reversing blindness in mucous membrane pemphigoid. J\u00a0Dtsch Dermatol Ges 15(10):1024\u20131026. \n                        https:\/\/doi.org\/10.1111\/ddg.13317","journal-title":"J. Dtsch. Dermatol. Ges."}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4089-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4089-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4089-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T11:30:29Z","timestamp":1515583829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4089-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4089"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4089-y","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,14]]}}}